Trial NCT02684617

View at ClinicalTrials.gov 
Org. Study IDs: 3475-155
Secondary IDs: KEYNOTE-155 MK-3475-155

Last trial update was posted on 2021-03-01

MeSH Interventions

Pembrolizumab

MeSH Conditions

Hematologic Neoplasms

Other Conditions

rrCLL rrDLBCL rrMM

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID